Cost-of-illness of chronic leg ulcers in Germany
Cost-of-illness of chronic leg ulcers in Germany
复制标题
DOI：
10.1111/j.1742-481x.2010.00660.x
复制
发表时间：
2010-04-01
影响因子：
3.1
通讯作者：
Augustin, Matthias
中科院分区：
文献类型：
--
作者：
Purwins, Sandra;Herberger, Katharina;Augustin, Matthias
慢性伤口很重要，因为它们的频率、长期性和治疗费用很高。然而，关于德国疾病成本的主要数据很少。目的是确定德国腿部静脉溃疡 (VLU) 的疾病成本。德国 23 个专业伤口中心进行了前瞻性疾病成本研究。记录了患者、法定健康保险公司和社会的直接、医疗、非医疗和间接费用。此外，使用弗莱堡伤口生活质量评估（FLQA-w，Augustin）将与健康相关的生活质量（QoL）记录为无形成本。连续招募了 218 名患者（62.1% 女性）。平均年龄为 69.8 +/- 12.0 岁。溃疡每年和患者的平均总费用为 (sic)9569，[(sic)8658.10 (92%) 直接费用和 (sic)911.20 (8%) 间接费用]。在直接费用中，(原文如此)7630.70 由法定健康保险承担，(原文如此)1027.40 由患者承担。主要成本因素是住院费用、门诊护理和非药物治疗。大多数患者的生活质量显着下降。在德国，VLU 与高昂的直接和间接成本相关。因此，需要早期和合格的疾病管理。如果要改善慢性伤口的管理，就必须进行更深入的疾病成本研究和成本效益分析。
Chronic wounds are important because of their frequency, their chronicity and high costs of treatment. However, there are few primary data on the cost-of-illness in Germany. The aim was to determine the cost-of-illness of venous leg ulcers (VLU) in Germany. Prospective cost-of-illness study was performed in 23 specialised wound centres throughout Germany. Direct, medical, non medical and indirect costs to the patient, statutory health insurers and society were documented. Thereover, health-related quality of life (QoL)was recorded as intangible costs using the Freiburg quality of life assessment for wounds (FLQA-w, Augustin). A total of 218 patients (62.1% female) were recruited consecutively. Mean age was 69.8 +/- 12.0 years. The mean total cost of the ulcer per year and patient was (sic)9569, [(sic)8658.10 (92%) direct and (sic)911.20 (8%) indirect costs]. Of the direct costs, (sic)7630.70 was accounted for by the statutory health insurance and (sic)1027.40 by the patient. Major cost factors were inpatient costs, outpatient care and non drug treatments. QoL was strikingly reduced in most patients. In Germany, VLU are associated with high direct and indirect costs. As a consequence, there is a need for early and qualified disease management. Deeper-going cost-of-illness-studies and cost-benefit analyses are necessary if management of chronic wounds is to be improved.